drugset / Trial / NCT00228423

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)

NCT00228423

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether the combination of clopidogrel with aspirin prevents the development of blockages (atherosclerosis) in vein grafts one year after coronary artery bypass surgery (CABG) compared to aspirin alone.

Timeline

Start
2006-05
Primary completion
2009-06
Completion
2009-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg

Indications